Corticosteroids and Anti-Complement Therapy in Retinal Diseases.

Abstract

Corticosteroids are unique in that they are the one class of agents that acts upon most of the multiple processes in the pathophysiology of macular edema. Corticosteroids are capable of inhibiting prostaglandin and leukotriene synthesis as well as interfering with intercellular adhesion molecule-1 (ICAM-1), interleukin-6, VEGF-A, and stromal cell derived… (More)
DOI: 10.1007/164_2016_22

Topics

Cite this paper

@article{Narayanan2017CorticosteroidsAA, title={Corticosteroids and Anti-Complement Therapy in Retinal Diseases.}, author={Raja Narayanan and Baruch D. Kuppermann}, journal={Handbook of experimental pharmacology}, year={2017}, volume={242}, pages={309-320} }